I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Piha-Paul, Sarina
352
results:
Search for persons
X
Format
Online (352)
Mediatypes
Articles (Online) (166)
OpenAccess-fulltext (185)
Audio (Online) (1)
Sorted by: Relevance
Sorted by: Year
?
1
First-In-Human Phase I Study of Tinengotinib (TT-00420), a ..:
Piha-Paul, Sarina A
;
Xu, Binghe
;
Dumbrava, Ecaterina E
...
The Oncologist. 29 (2024) 4 - p. e514-e525 , 2024
Link:
https://doi.org/10.1093/..
?
2
Initial Chemotherapy for Locally Advanced and Metastatic NU..:
Luo, Jia
;
Sanchez, Michelle
;
Lee, Elinton
...
Journal of Thoracic Oncology. 19 (2024) 5 - p. 829-838 , 2024
Link:
https://doi.org/10.1016/..
?
3
Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TA..:
Subbiah, Vivek
;
Coleman, Niamh
;
Piha-Paul, Sarina A.
...
Cancer Research Communications. 4 (2024) 2 - p. 378-387 , 2024
Link:
https://doi.org/10.1158/..
?
4
RAF inhibitor re-challenge therapy in BRAF-aberrant pan-can..:
Nelson, Blessie Elizabeth
;
Roszik, Jason
;
Ahmed, Jibran
...
Molecular Cancer. 23 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1186/..
?
5
A Relative Bioavailability, Bioequivalence, and Food Effect..:
Falchook, Gerald
;
Patnaik, Amita
;
Richardson, Debra L.
...
Clinical Therapeutics. 46 (2024) 3 - p. 228-238 , 2024
Link:
https://doi.org/10.1016/..
?
6
Antitumour activity of neratinib in patients with HER2-muta..:
Harding, James J.
;
Piha-Paul, Sarina A.
;
Shah, Ronak H.
...
Nature Communications. 14 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
7
SOLAR: Phase Ib Dose Expansion of Selumetinib (MEK Inhibito..:
Westin, Shannon
;
Kurnit, Katherine
;
Fellman, Bryan
...
Gynecologic Oncology. 176 (2023) - p. S33 , 2023
Link:
https://doi.org/10.1016/..
?
8
Complex I inhibitor of oxidative phosphorylation in advance..:
Yap, Timothy A.
;
Daver, Naval
;
Mahendra, Mikhila
...
Nature Medicine. , 2023
Link:
https://doi.org/10.1038/..
?
9
Predictors of Oncologic Outcome in Patients Receiving Phase..:
Son, Ji
;
Lin, Heather Y.
;
Fu, Siqing
...
Journal of Immunotherapy and Precision Oncology. 6 (2023) 1 - p. 10-18 , 2023
Link:
https://doi.org/10.36401..
?
10
BRAF v600E–mutant cancers treated with vemurafenib alone or..:
Nelson, Blessie Elizabeth
;
Roszik, Jason
;
Janku, Filip
...
npj Precision Oncology. 7 (2023) 1 - p. , 2023
Link:
https://doi.org/10.1038/..
?
11
Impact of Biomarker-Matched Therapies on Outcomes in Patien..:
Carmagnani Pestana, Roberto
;
Moyers, Justin T.
;
Roszik, Jason
...
Clinical Cancer Research. 29 (2023) 9 - p. 1708-1718 , 2023
Link:
https://doi.org/10.1158/..
?
12
A Phase I Trial of Bevacizumab and Temsirolimus in Combinat..:
Nelson, Blessie Elizabeth
;
Tsimberidou, Apostolia M
;
Fu, Xueyao
...
The Oncologist. 28 (2023) 12 - p. 1100-e1292 , 2023
Link:
https://doi.org/10.1093/..
?
13
Multidisciplinary Care of a Large Brain Metastasis in a Pat..:
Chelariu-Raicu, Anca
;
Piha-Paul, Sarina A.
;
Chavez-MacGregor, Mariana
...
Journal of Immunotherapy and Precision Oncology. 6 (2023) 3 - p. 158-161 , 2023
Link:
https://doi.org/10.36401..
?
14
Selinexor in combination with weekly paclitaxel in patients..:
Westin, Shannon N.
;
Fu, Siqing
;
Tsimberidou, Apostolia
...
Gynecologic Oncology. 168 (2023) - p. 76-82 , 2023
Link:
https://doi.org/10.1016/..
?
15
A phase I trial of the pan-ERBB inhibitor neratinib combine..:
Piha-Paul, Sarina A.
;
Tseng, Chieh
;
Tran, Hai T.
...
Cancer Chemotherapy and Pharmacology. 92 (2023) 2 - p. 107-118 , 2023
Link:
https://doi.org/10.1007/..
1-15